Intense stress and fear have long been known to give rise to a suppression of pain termed ''stress-induced analgesia", mediated by brainstem pain-modulating circuitry, including pain-inhibiting neurons of the rostral ventromedial medulla. However, stress does not invariably suppress pain, and indeed, may exacerbate it. Although there is a growing support for the idea of ''stress-induced hyperalgesia", the neurobiological basis for this effect remains almost entirely unknown. Using simultaneous single-cell recording and functional analysis, we show here that stimulation of the dorsomedial nucleus of the hypothalamus, known to be a critical component of central mechanisms mediating neuroendocrine, cardiovascular and thermogenic responses to mild or ''emotional" stressors such as air puff, also triggers thermal hyperalgesia by recruiting pain-facilitating neurons, ''ON-cells", in the rostral ventromedial medulla. Activity of identified RVM ON-cells, OFF-cells and NEUTRAL cells, nociceptive withdrawal thresholds, rectal temperature, and heart rate were recorded in lightly anesthetized rats. In addition to the expected increases in body temperature and heart rate, disinhibition of the DMH induced a robust activation of ON-cells, suppression of OFF-cell firing and behavioral hyperalgesia. Blocking ON-cell activation prevented hyperalgesia, but did not interfere with DMH-induced thermogenesis or tachycardia, pointing to differentiation of neural substrates for autonomic and nociceptive modulation within the RVM. These data demonstrate a top-down activation of brainstem pain-facilitating neurons, and suggest a possible neural circuit for stress-induced hyperalgesia.
Introduction
Intense stress and fear are known to suppress pain, a phenomenon termed ''stress-induced analgesia" [41, 71] . However, stress can also give rise to an increase in pain sensitivity, referred to as ''stress-induced hyperalgesia." Thus, repeated swim stress, acute and chronic restraint, novelty, horizontal rotation, and social defeat have all been shown to induce hyperalgesia in animals [2, 10, 17, 19, 33, 39, 42, 51, 54, 55, 63, 69] . This phenomenon is not simple hyper-reflexia, since anxiety or anticipation of pain can be shown to enhance pain sensitivity in humans [1, 4, 52, 53, 66] , and since stress is often asserted to exacerbate chronic clinical pain (see [9, 40, 70] for example). The parameters that differentiate stress-induced analgesia from hyperalgesia are as yet unknown, but intensity or aversiveness of the stressor may interact with arousal level in determining whether the net effect is to enhance or to suppress pain [18, 36, 46, 72] .
Stress-induced analgesia is mediated by brainstem pain-modulating systems [5, 71] , whereas the neural circuitry responsible for stress-induced hyperalgesia remains almost unknown. The dorsomedial nucleus of the hypothalamus (DMH) is a critical component of the central mechanisms mediating neuroendocrine, cardiovascular and thermogenic responses to various stressors [11, 12] . This raises the possibility that the DMH also contributes to stress-induced hyperalgesia through direct and indirect connections with the rostral ventromedial medulla (RVM), a region long implicated in descending control of nociception [13, 20, 57, 59 ].
The present experiments were designed to determine whether activation of the DMH would recruit pain-modulating circuitry of the RVM to facilitate nociception. Because of the functional overlap of autonomic control and pain-modulation in the RVM region, we used electrophysiological methods to record the responses of physiologically characterized RVM neurons to stimulation of the DMH, and pharmacological manipulation to test their roles in behavioral hyperalgesia. RVM neurons can be classified as NEUTRAL cells, ONcells, or OFF-cells. The physiological function of NEUTRAL cells remains unknown, but OFF-cells suppress, and ON-cells facilitate, nociception [20] . OFF-cells have been implicated in stress-induced analgesia related to conditioned fear [45] . By contrast, ON-cells are activated by the anxiogenic peptide cholecystokinin, which has been implicated in stress-induced hyperalgesia [24, 42] 
